《药物安全》是唯一一本涵盖药物警戒、药物流行病学和效益风险评估等学科的国际评论期刊。药物安全组织的同行评审委托文章结构化计划确保了所有主题的全面覆盖。高质量的原始研究集中在药物治疗安全问题的临床意义也发表了。药物安全专门对个别药物或药物类别的流行病学、临床特征、预防和不良反应管理进行最终审查。利益风险评估为您提供对特定疾病中药物的不良反应和疗效数据的深入审查。药物安全性还包括对药物使用特别是“高危”患者群体的审查，以及对药物警戒、风险最小化和药物差错预防的当前思维的概念审查。文章侧重于确保最安全地使用药物的实际方面，包括对不良反应的分析和解释、上市后监测和药物流行病学。
http://www.springer.com/journal/40264/submission
Drug Safety is the only international review journal covering the disciplines of pharmacovigilance, pharmacoepidemiology and benefit-risk assessment. Drug Safety's structured programme of peer reviewed commissioned articles ensures comprehensive coverage of all topics. High quality original research focusing on the clinical implications of drug treatment safety issues is also published. Drug Safety specialises in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs or drug classes. Benefit-risk assessments provide you with an in-depth review of adverse effect and efficacy data for a drug in a specific disease. Drug Safety also features reviews covering drug use in particular 'at-risk' patient groups, and concept reviews of current thinking in pharmacovigilance, risk minimisation and medication error prevention. Articles focus on the practical aspects of ensuring the safest possible use of drugs, including analysis and interpretation of adverse effects, post-marketing surveillance and pharmacoepidemiology.
